GOMA, Democratic Republic of Congo (Reuters) – Well being authorities in Democratic Republic of Congo mentioned on Saturday that they plan to introduce a second Ebola vaccine, manufactured by Johnson & Johnson, to counter the continuing outbreak.

The workforce overseeing Congo’s Ebola response didn’t say in a press release when precisely the J&J vaccine could be launched. It is going to complement one other vaccine manufactured by Merck, which has been administered to greater than 225,000 individuals since August of final 12 months.

Reporting by Fiston Mahamba; Writing by Aaron Ross; Enhancing by Giles Elgood

Source link